Reduced glucose metabolism in parietal, temporal and posterior cingulate regions, as assessed with FDG-PET, was previously linked to APOE ε4 in non-demented subjects, and in subjects at risk of AD [9, 70, 71]. The gene discussed is APOE; the disease is Alzheimer disease.